Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lu Daopei Medical Group is a leading private hematology hospital group in China, specializing in the treatment of blood disorders such as leukemia and lymphoma. Founded by Professor Lu Daopei, a pioneer in bone marrow transplantation, the group operates several specialized facilities including the Hebei Yanda Lu Daopei Hospital and Beijing Lu Daopei Hospital. The organization is globally recognized for its high volume of hematopoietic stem cell transplantations (HSCT) and its extensive clinical research in CAR-T cell therapies. By integrating clinical care with advanced laboratory diagnostics and research, the group provides comprehensive services for complex hematologic cases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ludaopei Medical Group.